GPR183 antagonist-3 (compound 33) is an oral active GPR183 antagonist with the IC50 of 8.7 µM. GPR183 antagonist-3 displays strong in vitro antimigration and anti-inflammatory activity in monocytes, and improves the pathological symptoms of DSS-induced experimental colitis[1].
Molecular Weight:
471.37
Purity:
98.79
Formula:
C21H19BrN4O2S
Target:
EBI2/GPR183
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted